Neuphoria Therapeutics Inc: Detailed Company Information & Corporate Profile
Summary
Neuphoria Therapeutics Inc operates from Burlington, Massachusetts, providing biopharmaceutical solutions within the biotech sector. With a lean team of 1–10 employees and annual revenues ranging between $10 million and $50 million, the company focuses on developing therapies for central nervous system disorders.
Its portfolio centers on anxiety conditions—including PTSD and social anxiety—alongside broader neuropsychiatric applications, positioning Neuphoria at the intersection of neuroscience research and therapeutic innovation.
Leadership includes President Steven Smith; Financial Controller Allison Piesendel; Interim CEO and Board Director Spyros Papapetropoulos, MD; Chief Medical Officer Bob Corringham; Manager of Strategic Initiatives & Innovation Carolyn Coles; Neuroscience Business Development Advisor Sue O'Connor; Senior Research Assistant Michaela Scherer; Non‑Executive Chair Alan Fisher; and Assistant Controller Elena Chokler.
| Neuphoria Therapeutics Inc Website | neuphoriatx.com |
| Phone Number | +1 (781) 730-6665 |
| Industries | |
| Neuphoria Therapeutics Inc Headquarters Address | 100 Summit Dr, Burlington, Massachusetts, 01803 US |
| Company Size | 1-10 employees |
| Specialities & Services | biopharmaceutical, central nervous system disorders, anxiety, PTSD, social anxiety, neuropsychiatry |
| Estimated Annual Revenue | $10M - 50M |
| Updated: | 2026-10-30 |
Estimated Website Traffic
The chart shows a growth in traffic to the neuphoriatx.com website. In September, traffic increased to 1285, compared to 1244 in the previous month. The highest traffic in 2026 was recorded in January, reaching 1748 visits.
Workforce Turnover
Length of Employment
Neuphoria Therapeutics Inc's workforce includes employees across a wide range of tenure levels.
14% have been with the company for 5 to 7 years14% have been with the company for 8 to 10 years71% have been with the company for more than 11 years
Companies Similar to Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
